NeoGenomics, Inc.
Symbol: NEO (NASDAQ)
Company Description:
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
- Today's Open: $5.195
- Today's High: $5.254
- Today's Low: $5.117
- Today's Volume: 2.07M
- Yesterday Close: $4.84
- Yesterday High: $5.11
- Yesterday Low: $4.78
- Yesterday Volume: 4.40M
- Last Min Volume: 600
- Last Min High: $5.155
- Last Min Low: $5.155
- Last Min VWAP: $5.155
- Name: NeoGenomics, Inc.
- Website: https://www.neogenomics.com
- Listed Date: 1996-01-25
- Location: FORT MYERS, FL
- Market Status: Active
- CIK Number: 0001077183
- SIC Code: 8734
- SIC description: SERVICES-TESTING LABORATORIES
- Market Cap: $666.56M
- Round Lot: 100
- Outstanding Shares: 129.18M
- Asset Type: CS
Filing Date | Filing Type | Format |
---|---|---|
2025-07-29 | 10-Q | View |
2025-07-29 | 8-K | View |
2025-07-17 | SCHEDULE 13G/A | View |
2025-06-24 | 4 | View |
2025-06-24 | 3 | View |
2025-06-24 | 8-K | View |
2025-06-16 | S-8 | View |
2025-06-03 | 4/A | View |
2025-06-03 | 4 | View |
2025-06-03 | 4 | View |
2025-06-03 | 4 | View |
2025-06-03 | 4 | View |
2025-06-03 | 4 | View |
2025-06-03 | 4 | View |
2025-06-03 | 4 | View |
2025-06-03 | 4 | View |
2025-06-03 | 4 | View |
2025-05-28 | 4 | View |
2025-05-27 | 8-K | View |
2025-05-14 | SCHEDULE 13G/A | View |